ASTL

astacin like metalloendopeptidase, the group of Astacins

Basic information

Region (hg38): 2:96122818-96138502

Links

ENSG00000188886NCBI:431705OMIM:608860HGNC:31704Uniprot:Q6HA08AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Oocyte/zygote/embryo maturation arrest 11ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingObstetric34704130
Attempts at IVF and assisted reproduction were not reported as successful

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ASTL gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASTL gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
clinvar
2
missense
25
clinvar
5
clinvar
1
clinvar
31
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 25 6 3

Variants in ASTL

This is a list of pathogenic ClinVar variants found in the ASTL region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-96123863-AT-A Benign (Aug 21, 2018)780829
2-96123872-A-T not specified Uncertain significance (Apr 18, 2023)2538347
2-96123911-C-T not specified Uncertain significance (Jun 11, 2024)3319029
2-96124091-T-C not specified Likely benign (Mar 18, 2024)3319047
2-96124104-A-G not specified Likely benign (Mar 26, 2024)3319075
2-96124110-A-G not specified Uncertain significance (Oct 13, 2023)3130530
2-96124128-C-T not specified Uncertain significance (Aug 17, 2021)2346631
2-96124143-C-T not specified Uncertain significance (Dec 18, 2023)3130529
2-96124193-G-A not specified Uncertain significance (Mar 07, 2024)2400296
2-96124196-G-A not specified Likely benign (Jan 04, 2022)2305618
2-96124221-G-T not specified Uncertain significance (Nov 03, 2022)2365103
2-96124234-C-T Likely benign (Nov 01, 2022)2651138
2-96124235-G-A not specified Likely benign (Feb 23, 2023)2457080
2-96124235-G-T not specified Uncertain significance (Mar 01, 2023)2492414
2-96124244-C-T not specified Uncertain significance (Jan 18, 2022)2271833
2-96129826-C-T Benign (Jul 13, 2018)791863
2-96129860-C-T not specified Uncertain significance (Jul 27, 2022)2352231
2-96129877-C-T not specified Uncertain significance (May 18, 2022)2393356
2-96129925-C-T not specified Uncertain significance (Apr 15, 2024)3319086
2-96130092-C-T not specified Uncertain significance (Jul 17, 2023)2612443
2-96130114-G-C not specified Uncertain significance (Jun 02, 2024)3319097
2-96132549-T-C not specified Uncertain significance (Jul 09, 2021)2210158
2-96132552-C-G not specified Uncertain significance (Nov 09, 2021)2259910
2-96132567-G-A Likely benign (Aug 01, 2023)2651139
2-96132647-C-T not specified Uncertain significance (Apr 13, 2022)3130534

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ASTLprotein_codingprotein_codingENST00000342380 914587
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
6.05e-70.69112549332521257480.00101
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2882572700.9510.00001642760
Missense in Polyphen6080.5170.74519822
Synonymous0.6061041120.9270.00000712925
Loss of Function1.161217.20.6999.00e-7170

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002650.000265
Ashkenazi Jewish0.000.00
East Asian0.0002720.000272
Finnish0.00004620.0000462
European (Non-Finnish)0.0001590.000158
Middle Eastern0.0002720.000272
South Asian0.007060.00698
Other0.001630.00163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Oocyte-specific oolemmal receptor involved in sperm and egg adhesion and fertilization. Plays a role in the polyspermy inhibition. Probably acts as a protease for the post-fertilization cleavage of ZP2. Cleaves the sperm-binding ZP2 at the surface of the zona pellucida after fertilization and cortical granule exocytosis, rendering the zona pellucida unable to support further sperm binding (By similarity). {ECO:0000250}.;

Recessive Scores

pRec
0.0962

Intolerance Scores

loftool
0.696
rvis_EVS
0.71
rvis_percentile_EVS
85.73

Haploinsufficiency Scores

pHI
0.0802
hipred
N
hipred_score
0.123
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.193

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Astl
Phenotype
reproductive system phenotype;

Gene ontology

Biological process
proteolysis;cell adhesion;fertilization;positive regulation of protein processing;prevention of polyspermy;negative regulation of binding of sperm to zona pellucida
Cellular component
cytoplasm;plasma membrane;transport vesicle;cortical granule
Molecular function
metalloendopeptidase activity;peptidase activity;zinc ion binding;aspartic-type peptidase activity;glutamic-type peptidase activity